Ben Adams is an Author and Speaker at Field Sim. With a focus on the life safety industry and a deep expertise in healthcare technology and pharmaceuticals, he explores themes such as digital health, wellness programs, and mental health. Ben's insights and writings have been featured in notable publications including BuzzFeed, The Telegraph, and Fierce Pharma.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ben Adams primarily covers the health and pharmaceutical industries, focusing on corporate rebranding, drug advertising spending, regulatory petitions, and industry events. He also reports on healthcare-related initiatives and celebrity endorsements.
Given his focus on press releases and private sector announcements in the health and pharmaceutical industries, Ben is likely to be receptive to pitches that offer exclusive insights into major corporate developments within the sector. This could include new product launches or significant organizational changes within prominent companies.
Furthermore, given his coverage of regulatory petitions related to misleading promotions in the pharmaceutical industry, he may be interested in commentary from experts who can provide insight into legal or ethical issues surrounding healthcare marketing practices.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Plus Therapeutics is evolving its business and has rebranded as Cerenome to reflect its expansion.
Caris Life Sciences has launched a new oncology blood test designed alongside AI modelling to pick up cancer at earlier stages.
By: Ben Adams
Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system for prostate cancer screening and is boosting its commercial team to help.
By: Ben Adams
Healthcare comms and AI marketing firm Real Chemistry has set up its first Asia Pacific strategic hub in Singapore with the acquisition of Spurwing Communications.
Women in England are set to gain new, taxpayer-funded tests for endometriosis after NICE recommended them for regular use.
As Novo Nordisk looks for new ways to broaden its semaglutide GLP-1 franchise, the Danish drugmaker has signed a new deal with Californian medtech Vivani Medical to help.
By: Ben Adams
Novo Nordisk is running an exhibition in central London designed to start a dialogue on obesity and help remove the stigma surrounding the condition.
By: Ben Adams
After several months of AbbVie leading pharma's monthly ad spend, Johnson & Johnson is back as Tremfya topped June's rankings.
By: Ben Adams
An ear-based wearable device that taps the body's longest cranial nerve can boost blood clotting in what researchers are hopeful could be a new way of treating severe bleeding.
By: Ben Adams
In the second of a new series of interviews with top executives from leading healthcare and comms agencies, Fierce Pharma Marketing sat down with London-based Havas SO's managing director, Joanna Quade and Creative Director, Lucy Doolan.
